A global genomic analysis of Salmonella Concord reveals lineages with high antimicrobial resistance in Ethiopia.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
14 06 2023
Historique:
received: 13 02 2023
accepted: 22 05 2023
medline: 16 6 2023
pubmed: 15 6 2023
entrez: 14 6 2023
Statut: epublish

Résumé

Antimicrobial resistant Salmonella enterica serovar Concord (S. Concord) is known to cause severe gastrointestinal and bloodstream infections in patients from Ethiopia and Ethiopian adoptees, and occasional records exist of S. Concord linked to other countries. The evolution and geographical distribution of S. Concord remained unclear. Here, we provide a genomic overview of the population structure and antimicrobial resistance (AMR) of S. Concord by analysing genomes from 284 historical and contemporary isolates obtained between 1944 and 2022 across the globe. We demonstrate that S. Concord is a polyphyletic serovar distributed among three Salmonella super-lineages. Super-lineage A is composed of eight S. Concord lineages, of which four are associated with multiple countries and low levels of AMR. Other lineages are restricted to Ethiopia and horizontally acquired resistance to most antimicrobials used for treating invasive Salmonella infections in low- and middle-income countries. By reconstructing complete genomes for 10 representative strains, we demonstrate the presence of AMR markers integrated in structurally diverse IncHI2 and IncA/C2 plasmids, and/or the chromosome. Molecular surveillance of pathogens such as S. Concord supports the understanding of AMR and the multi-sector response to the global AMR threat. This study provides a comprehensive baseline data set essential for future molecular surveillance.

Identifiants

pubmed: 37316492
doi: 10.1038/s41467-023-38902-x
pii: 10.1038/s41467-023-38902-x
pmc: PMC10267216
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3517

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10349
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R012504/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_16093
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/CCG1720/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Bull World Health Organ. 1982;60(5):803-7
pubmed: 6983931
Trop Anim Health Prod. 1981 Nov;13(4):203-7
pubmed: 7344186
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Emerg Infect Dis. 2014 Nov;20(11):1957-9
pubmed: 25340988
J Antimicrob Chemother. 2006 May;57(5):1012-4
pubmed: 16531428
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Genome Biol. 2021 Sep 14;22(1):266
pubmed: 34521459
J Bacteriol. 1944 Jun;47(6):574-5
pubmed: 16560807
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
Antimicrob Agents Chemother. 2014 Oct;58(10):5696-703
pubmed: 25022583
Genome Biol. 2021 Dec 21;22(1):349
pubmed: 34930397
Lancet Infect Dis. 2022 May;22(5):692-705
pubmed: 35114140
Pediatr Infect Dis J. 2009 Sep;28(9):814-8
pubmed: 19710587
Clin Infect Dis. 2001 Jan 15;32(2):263-9
pubmed: 11170916
Methods Mol Biol. 2014;1079:155-70
pubmed: 24170401
Appl Environ Microbiol. 2019 Nov 14;85(23):
pubmed: 31540993
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Antimicrob Chemother. 2021 May 12;76(6):1459-1466
pubmed: 33704480
PLoS Negl Trop Dis. 2020 Aug 3;14(8):e0008440
pubmed: 32745137
Front Public Health. 2019 Nov 21;7:317
pubmed: 31824904
Vaccine. 2015 Jun 19;33 Suppl 3:C21-9
pubmed: 25912288
Antimicrob Agents Chemother. 2015;59(6):3133-9
pubmed: 25779570
J Bacteriol. 2005 Jul;187(13):4401-9
pubmed: 15968049
Antimicrob Agents Chemother. 2006 Apr;50(4):1608-9
pubmed: 16569897
J Antimicrob Chemother. 2015 Jan;70(1):75-80
pubmed: 25190723
Bioinformatics. 2010 Sep 15;26(18):2334-5
pubmed: 20624783
J Infect Dev Ctries. 2011 Feb 01;5(1):23-33
pubmed: 21330737
PLoS Negl Trop Dis. 2020 Apr 2;14(4):e0008121
pubmed: 32240161
Lancet. 2012 Jun 30;379(9835):2489-2499
pubmed: 22587967
Antimicrob Agents Chemother. 2014 Jul;58(7):3785-90
pubmed: 24752261
Trends Microbiol. 2018 Dec;26(12):986-998
pubmed: 29954653
Bioinformatics. 2018 Mar 1;34(5):867-868
pubmed: 29096012
Nat Biotechnol. 2019 May;37(5):540-546
pubmed: 30936562
Bioinformatics. 2019 Nov 1;35(21):4453-4455
pubmed: 31070718
Antimicrob Agents Chemother. 2020 Jul 22;64(8):
pubmed: 32513803
Front Microbiol. 2014 Aug 04;5:391
pubmed: 25136336
J Antimicrob Chemother. 2005 Jul;56(1):115-21
pubmed: 15941775
Genome Res. 2020 Jan;30(1):138-152
pubmed: 31809257
Antimicrob Resist Infect Control. 2019 Feb 15;8:39
pubmed: 30815254
Nucleic Acids Res. 2019 Jun 20;47(11):5539-5549
pubmed: 31076776
Clin Microbiol Infect. 2021 Dec;27(12):1856.e7-1856.e13
pubmed: 33915285
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Microbiol Spectr. 2014 Feb;2(1):OH-0020-2013
pubmed: 26082128
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
J Antimicrob Chemother. 2010 May;65(5):872-5
pubmed: 20200038
Antimicrob Agents Chemother. 2009 May;53(5):1808-16
pubmed: 19273688
Avian Dis. 1982 Apr-Jun;26(2):234-44
pubmed: 7103885
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Microb Genom. 2020 Apr;6(4):
pubmed: 32160146
PLoS One. 2021 Dec 2;16(12):e0256556
pubmed: 34855767
Genome Biol. 2015 Dec 29;16:294
pubmed: 26714481
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
Microb Genom. 2019 Jul;5(7):
pubmed: 31107206
J Infect. 2008 Jun;56(6):413-22
pubmed: 18474400
Microb Genom. 2021 May;7(5):
pubmed: 33961543
Germs. 2021 Mar 15;11(1):88-96
pubmed: 33898345
Emerg Infect Dis. 2011 Jan;17(1):97-9
pubmed: 21192864
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):491-7
pubmed: 21744280
Euro Surveill. 2010 Jun 10;15(23):
pubmed: 20546693
Nat Methods. 2020 Feb;17(2):155-158
pubmed: 31819265
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Ethiop Med J. 1985 Jul;23(3):97-102
pubmed: 4006927
Genome Res. 2004 Jul;14(7):1394-403
pubmed: 15231754
BMC Med. 2020 Jul 17;18(1):212
pubmed: 32677939
Euro Surveill. 2019 Mar;24(13):
pubmed: 30940315
Front Public Health. 2018 May 30;6:159
pubmed: 29900166
Lancet Infect Dis. 2019 Dec;19(12):1312-1324
pubmed: 31562022
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Int J Med Microbiol. 2011 Dec;301(8):654-8
pubmed: 21992746
Nat Commun. 2019 Sep 19;10(1):4280
pubmed: 31537784
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31427293
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Methods. 2013 Jun;10(6):563-9
pubmed: 23644548
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Antimicrob Resist Infect Control. 2021 May 10;10(1):79
pubmed: 33971966
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668
J Trop Med. 2020 Apr 30;2020:6167234
pubmed: 32411256
Int J Antimicrob Agents. 2005 Jul;26(1):33-7
pubmed: 15953709
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Wim L Cuypers (WL)

Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium. wim.cuypers@uantwerpen.be.
Unit of Tropical Bacteriology, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. wim.cuypers@uantwerpen.be.

Pieter Meysman (P)

Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium.

François-Xavier Weill (FX)

Institut Pasteur, Université Paris Cité, Unité des bactéries pathogènes entériques, F-75015, Paris, France.

Rene S Hendriksen (RS)

Technical University of Denmark, National Food Institute (DTU-Food), Research Group of Global Capacity Building, Kgs., Lyngby, Denmark.

Getenet Beyene (G)

Department of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma University, Jimma, Ethiopia.

John Wain (J)

Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Norwich Medical School, University of East Anglia, Norwich, UK.

Satheesh Nair (S)

Gastrointestinal Bacterial Reference Unit, United Kingdom Health Security Agency, Colindale, London, UK.

Marie A Chattaway (MA)

Gastrointestinal Bacterial Reference Unit, United Kingdom Health Security Agency, Colindale, London, UK.

Blanca M Perez-Sepulveda (BM)

Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK.

Pieter-Jan Ceyssens (PJ)

Division of Human Bacterial Diseases, Sciensano, Brussels, Belgium.

Tessa de Block (T)

Clinical Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Winnie W Y Lee (WWY)

Gastrointestinal Bacterial Reference Unit, United Kingdom Health Security Agency, Colindale, London, UK.
MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, UK.

Maria Pardos de la Gandara (M)

Institut Pasteur, Université Paris Cité, Unité des bactéries pathogènes entériques, F-75015, Paris, France.

Christian Kornschober (C)

Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology and Hygiene, 8010, Graz, Austria.

Jacob Moran-Gilad (J)

Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.

Kees T Veldman (KT)

Department of Bacteriology, Host Pathogen Interaction & Diagnostics, Wageningen Bioveterinary Research, Lelystad, The Netherlands.

Martin Cormican (M)

Antimicrobial Resistance and Microbial Ecology Group, School of Medicine, University of Galway, Galway, Ireland.

Mia Torpdahl (M)

Department of Bacteriology, Mycology & Parasitology, Statens Serum Institut, 5 Artillerivej, DK-2300, Copenhagen S, Denmark.

Patricia I Fields (PI)

Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Tomáš Černý (T)

National Reference Laboratory for salmonella, State Veterinary Institute Prague, Prague, Czech Republic.

Liselotte Hardy (L)

Unit of Tropical Bacteriology, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Bieke Tack (B)

Unit of Tropical Bacteriology, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Kate C Mellor (KC)

London School of Hygiene and Tropical Medicine, Bloomsbury, London, UK.
Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom.

Nicholas Thomson (N)

London School of Hygiene and Tropical Medicine, Bloomsbury, London, UK.
Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom.

Gordon Dougan (G)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID),Department of Medicine, University of Cambridge, Cambridge, CB2 0SP, United Kingdom.

Stijn Deborggraeve (S)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Jan Jacobs (J)

Unit of Tropical Bacteriology, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Kris Laukens (K)

Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium.

Sandra Van Puyvelde (S)

Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom. sandra.vanpuyvelde@uantwerpen.be.
Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID),Department of Medicine, University of Cambridge, Cambridge, CB2 0SP, United Kingdom. sandra.vanpuyvelde@uantwerpen.be.
Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. sandra.vanpuyvelde@uantwerpen.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH